Insights on alcohol reduction and mental wellness

Tirzepatide and Alcohol Cravings: What the Early Evidence Shows

Tirzepatide (Mounjaro/Zepbound) may reduce alcohol cravings via dual GLP-1 and GIP brain pathways. Here's what the research shows and how it compares to naltrexone.

Benefits of Drinking Less Alcohol: What the Research Shows

You don't have to quit entirely to feel better. Here's what happens to your body and mind when you cut back on alcohol, and how quickly it shows up.

Insomnia After Quitting Alcohol: Why It Happens and How Long It Lasts

Sleep problems after quitting alcohol are common and temporary. Here's what causes them, how long they last, and how to get through the worst of it.

Naltrexone vs Therapy for Alcohol: Why the Answer Is "And," Not "Or"

Naltrexone and behavioral therapy work on different mechanisms. Learn why combining both outperforms either alone, backed by the landmark COMBINE trial.

Ozempic and Alcohol: What the Research Actually Shows

Taking Ozempic or semaglutide and wondering about alcohol? Here's what happens when you drink on GLP-1 medications, the craving research, and what to know.

Is Naltrexone Safe for the Liver? A Clear, Evidence-Based Answer

The FDA removed naltrexone's liver warning in 2013. At 50mg, it's safe for most patients. Here's what the research actually shows about naltrexone and your liver.